Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

BACKGROUND

Prothrombin complex concentrate (PCC) can substantially shorten the time needed to reverse antivitamin K oral anticoagulant therapy (OAT). OBJECTIVES. To determine the effectiveness and safety of emergency OAT reversal by a balanced pasteurized nanofiltered PCC (Beriplex P/N) containing coagulation factors II, VII, IX, and X, and anticoagulant proteins C and S.

PATIENTS AND METHODS

Patients receiving OAT were eligible for this prospective multinational study if their International Normalized Ratio (INR) exceeded 2 and they required either an emergency surgical or urgent invasive diagnostic intervention or INR normalization due to acute bleeding. Stratified 25, 35, or 50 IU kg(-1) PCC doses were infused based on initial INR. Study endpoints included INR normalization (

RESULTS

Forty-three patients, 26 requiring interventional procedures and 17 experiencing acute bleeding, received PCC infusions at a median rate of 7.5 mL min(-1) (188 IU min(-1)). At 30 min thereafter, INR declined to

CONCLUSIONS

PCC treatment serves as an effective rapid hemorrhage control resource in the emergency anticoagulant reversal setting. More widespread availability of PCC is warranted to ensure its benefits in appropriate patients.

Collapse

Key Words Collapse

MESH Headings

• Adult
• Aged
• Aged, 80 and over
• Anticoagulants/adverse effects
• Coumarins/adverse effects
• Drug Combinations
• Emergencies
• Europe/epidemiology
• Factor IX/adverse effects
• Factor IX/therapeutic use
• Factor VII/adverse effects
• Factor VII/therapeutic use
• Factor X/adverse effects
• Factor X/therapeutic use
• Female
• Hemorrhage/chemically induced
• Hemorrhage/drug therapy
• Hemorrhage/prevention & control
• Hemostatics/adverse effects
• Hemostatics/therapeutic use
• Humans
• International Normalized Ratio
• Israel/epidemiology
• Male
• Middle Aged
• Prospective Studies
• Prothrombin/adverse effects
• Prothrombin/therapeutic use
• Pulmonary Embolism/chemically induced
• Vitamin K/therapeutic use

Collapse

Grants Collapse

Affiliation(s)

I Pabinger Department of Internal Medicine, Division of Haematology and Haemostaseology, Medical University Vienna, Vienna, Austria
B Brenner
U Kalina
S Knaub
A Nagy
H Ostermann

Collapse

Real-time optical detection of methicillin-resistant Staphylococcus aureus using lytic phage probes

Staphylococcus aureus (S. aureus)-specific bacteriophage was used as a probe for detection of methicillin-resistant S. aureus (MRSA) in aqueous solution using a novel optical method. Biorecognition phage monolayers transferred to glass substrates using Langmuir-Blodgett (LB) technique were exposed individually to MRSA in solution at logarithmic concentrations ranging from 10(6) to 10(9)cfu/ml, and observed for real-time binding using a CytoViva optical light microscope system. Results indicate that LB monolayers possessed high levels of elasticity (K), measuring 22 and 29 mN/m for 10(9) and 10(11)pfu/ml phage concentrations, respectively. Near-instantaneous MRSA-phage binding produced 33+/-5%, 10+/-1%, 1.1+/-0.1%, and 0.09+/-0.01% coverage of the substrate that directly correlated to a decrease in MRSA concentrations of 10(9), 10(8), 10(7), and 10(6)cfu/ml. The exclusive selectivity of phage monolayers was verified with Salmonella enterica subsp. enterica serovar typhimurium (S. typhimurium) and Bacillus subtilis.